Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hmed.2012.73.11.604 | DOI Listing |
BMJ Neurol Open
December 2024
Department of Clinical and Experimental Epilepsy and Chalfont Centre for Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
JHEP Rep
January 2025
Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Background & Aims: The dynamics of HBV viral load (VL) in patients with chronic hepatitis B (CHB) on nucleos(t)ide analogue (NA) treatment and its relationship with liver disease are poorly understood. We aimed to study longitudinal VL patterns and their associations with CHB clinical outcomes.
Methods: Utilising large scale, routinely collected electronic health records from six centres in England, collated by the National Institute for Health and Care Research Health Informatics Collaborative (NIHR HIC), we applied latent class mixed models to investigate VL trajectory patterns in adults receiving NA treatment.
Neuro Oncol
December 2024
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institut für Neuropathologie, Charitéplatz 1, 10117 Berlin, Germany.
Background: Intracerebral schwannomas are rare tumors resembling their peripheral nerve sheath counterparts but localized in the CNS. They are not classified as a separate tumor type in the 2021 WHO classification. This study aimed to compile and characterize these rare neoplasms morphologically and molecularly.
View Article and Find Full Text PDFLancet
December 2025
Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and the Royal Women's Hospital, Melbourne, VIC, Australia.
Am J Clin Nutr
December 2024
Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
Background: Impaired fetal and accelerated postnatal growth are associated with cardiometabolic disease. Few studies investigated how recovery from severe acute malnutrition (SAM) is associated with childhood cardiometabolic risk.
Objective: We evaluated cardiometabolic risk in SAM children treated through community-based management, relative to controls, 5-year post-recovery.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!